Digital Health, Technology & InnovationBayer Gives Update on Elinzanetant Menopause TreatmentBusiness WireJuly 28, 2025November 19, 2025 by Business WireJuly 28, 2025November 19, 20250126 Bayer today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinzanetant...
